All-Cause Mortality of Patients With and Without Diabetes Following Bariatric Surgery: Comparison to Non-surgical Matched Patients

[1]  F. Folli,et al.  A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesity , 2018, Cardiovascular Diabetology.

[2]  S. Haneuse,et al.  Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity , 2018, JAMA.

[3]  S. Msika,et al.  Association Between Bariatric Surgery and Rates of Continuation, Discontinuation, or Initiation of Antidiabetes Treatment 6 Years Later , 2018, JAMA surgery.

[4]  P. Greenland,et al.  Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality , 2018, JAMA.

[5]  Avis J. Thomas,et al.  Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study , 2018, JAMA.

[6]  K. Truong,et al.  The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis , 2017, Obesity Surgery.

[7]  S. Hunt,et al.  Weight and Metabolic Outcomes 12 Years after Gastric Bypass , 2017, The New England journal of medicine.

[8]  D. Carey,et al.  All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes , 2017, Diabetes Care.

[9]  Deepak L. Bhatt,et al.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5‐Year Outcomes , 2017, The New England journal of medicine.

[10]  Cheng Hu,et al.  Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients , 2016, Medicine.

[11]  A. Morabito,et al.  Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study , 2016, Cardiovascular Diabetology.

[12]  S. Vinker,et al.  Long-Term Outcomes of Three Types of Bariatric Surgery on Obesity and Type 2 Diabetes Control and Remission , 2016, Obesity Surgery.

[13]  S. Gudbjörnsdottir,et al.  Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. , 2015, The lancet. Diabetes & endocrinology.

[14]  S. Hunt,et al.  All-Cause and Cause-Specific Mortality Associated with Bariatric Surgery: A Review , 2015, Current Atherosclerosis Reports.

[15]  F. Rubino,et al.  Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial , 2015, The Lancet.

[16]  E. Livingston,et al.  Association between bariatric surgery and long-term survival. , 2015, JAMA.

[17]  M. Hoshen,et al.  Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel , 2014, Population Health Metrics.

[18]  D. Blackhurst,et al.  Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. , 2013, Journal of the American College of Surgeons.

[19]  Markku Peltonen,et al.  Cardiovascular Events After Bariatric Surgery in Obese Subjects With Type 2 Diabetes , 2012, Diabetes Care.

[20]  D. Dempsey,et al.  Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects , 2008 .

[21]  Claude Bouchard,et al.  Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.

[22]  W. Pories,et al.  The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus , 1997, Journal of Gastrointestinal Surgery.

[23]  Douglas E Schaubel,et al.  A Sequential Stratification Method for Estimating the Effect of a Time‐Dependent Experimental Treatment in Observational Studies , 2006, Biometrics.

[24]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[25]  F A Mathewson,et al.  Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. , 1977, The American journal of cardiology.